These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 29097913)
21. Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET. Xu Q; Zhu C; Xu Y; Pan D; Liu P; Yang R; Wang L; Chen F; Sun X; Luo S; Yang M J Drug Target; 2015; 23(9):813-20. PubMed ID: 25758750 [TBL] [Abstract][Full Text] [Related]
22. PET imaging with [⁶⁸Ga]NOTA-RGD for prostate cancer: a comparative study with [¹⁸F]fluorodeoxyglucose and [¹⁸F]fluoroethylcholine. Israel I; Richter D; Stritzker J; van Ooschot M; Donat U; Buck AK; Samnick S Curr Cancer Drug Targets; 2014; 14(4):371-9. PubMed ID: 24720338 [TBL] [Abstract][Full Text] [Related]
23. Comparative studies of three 68Ga-labeled [Des-Arg10]kallidin derivatives for imaging bradykinin B1 receptor expression with PET. Lin KS; Amouroux G; Pan J; Zhang Z; Jenni S; Lau J; Liu Z; Hundal-Jabal N; Colpo N; Bénard F J Nucl Med; 2015 Apr; 56(4):622-7. PubMed ID: 25745086 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of A Novel GLP-1R Ligand for PET Imaging of Prostate Cancer. Yue Y; Xu Y; Huang L; Pan D; Bai Z; Wang L; Yang R; Yan J; Song H; Li X; Yang M Anticancer Agents Med Chem; 2019; 19(4):509-514. PubMed ID: 30068284 [TBL] [Abstract][Full Text] [Related]
25. GRPR-selective PET imaging of prostate cancer using [(18)F]-lanthionine-bombesin analogs. Carlucci G; Kuipers A; Ananias HJ; de Paula Faria D; Dierckx RA; Helfrich W; Rink R; Moll GN; de Jong IJ; Elsinga PH Peptides; 2015 May; 67():45-54. PubMed ID: 25797109 [TBL] [Abstract][Full Text] [Related]
26. N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging. Gourni E; Mansi R; Jamous M; Waser B; Smerling C; Burian A; Buchegger F; Reubi JC; Maecke HR J Nucl Med; 2014 Oct; 55(10):1719-25. PubMed ID: 25146125 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and Characterization of a Novel PET Tracer for Noninvasive Evaluation of FGL1 Status in Tumors. Tan S; Ding X; Pan D; Xu Y; Wang C; Yan J; Chen C; Wang L; Wang X; Yang M; Xu Y Mol Pharm; 2024 Jul; 21(7):3425-3433. PubMed ID: 38836286 [TBL] [Abstract][Full Text] [Related]
28. Multivalent bifunctional chelator scaffolds for gallium-68 based positron emission tomography imaging probe design: signal amplification via multivalency. Singh AN; Liu W; Hao G; Kumar A; Gupta A; Öz OK; Hsieh JT; Sun X Bioconjug Chem; 2011 Aug; 22(8):1650-62. PubMed ID: 21740059 [TBL] [Abstract][Full Text] [Related]
29. Non-invasive glucagon-like peptide-1 receptor imaging in pancreas with (18)F-Al labeled Cys(39)-exendin-4. Mi B; Xu Y; Pan D; Wang L; Yang R; Yu C; Wan W; Wu Y; Yang M Biochem Biophys Res Commun; 2016 Feb; 471(1):47-51. PubMed ID: 26850848 [TBL] [Abstract][Full Text] [Related]
30. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice. Jeong JM; Hong MK; Chang YS; Lee YS; Kim YJ; Cheon GJ; Lee DS; Chung JK; Lee MC J Nucl Med; 2008 May; 49(5):830-6. PubMed ID: 18413379 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of Zhao M; Yang W; Zhang M; Li G; Wang S; Wang Z; Ma X; Kang F; Wang J Tumour Biol; 2016 Sep; 37(9):12123-12131. PubMed ID: 27220318 [TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography imaging of tumor angiogenesis with a 66Ga-labeled monoclonal antibody. Engle JW; Hong H; Zhang Y; Valdovinos HF; Myklejord DV; Barnhart TE; Theuer CP; Nickles RJ; Cai W Mol Pharm; 2012 May; 9(5):1441-8. PubMed ID: 22519890 [TBL] [Abstract][Full Text] [Related]
33. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET. Niedermoser S; Chin J; Wängler C; Kostikov A; Bernard-Gauthier V; Vogler N; Soucy JP; McEwan AJ; Schirrmacher R; Wängler B J Nucl Med; 2015 Jul; 56(7):1100-5. PubMed ID: 25977461 [TBL] [Abstract][Full Text] [Related]
34. Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging. Ebenhan T; Zeevaart JR; Venter JD; Govender T; Kruger GH; Jarvis NV; Sathekge MM J Nucl Med; 2014 Feb; 55(2):308-14. PubMed ID: 24434293 [TBL] [Abstract][Full Text] [Related]
35. (68)Ga small peptide imaging: comparison of NOTA and PCTA. Ferreira CL; Yapp DT; Mandel D; Gill RK; Boros E; Wong MQ; Jurek P; Kiefer GE Bioconjug Chem; 2012 Nov; 23(11):2239-46. PubMed ID: 23035991 [TBL] [Abstract][Full Text] [Related]
36. 44Sc-DOTA-BN[2-14]NH2 in comparison to 68Ga-DOTA-BN[2-14]NH2 in pre-clinical investigation. Is 44Sc a potential radionuclide for PET? Koumarianou E; Loktionova NS; Fellner M; Roesch F; Thews O; Pawlak D; Archimandritis SC; Mikolajczak R Appl Radiat Isot; 2012 Dec; 70(12):2669-76. PubMed ID: 23037921 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and preclinical evaluation of 68Ga-labeled collagelin analogs for imaging and quantification of fibrosis. Velikyan I; Rosenström U; Estrada S; Ljungvall I; Häggström J; Eriksson O; Antoni G Nucl Med Biol; 2014 Oct; 41(9):728-36. PubMed ID: 25023066 [TBL] [Abstract][Full Text] [Related]
38. The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26. Varasteh Z; Mitran B; Rosenström U; Velikyan I; Rosestedt M; Lindeberg G; Sörensen J; Larhed M; Tolmachev V; Orlova A Nucl Med Biol; 2015 May; 42(5):446-454. PubMed ID: 25684649 [TBL] [Abstract][Full Text] [Related]
39. (64)Cu- and (68)Ga-Based PET Imaging of Folate Receptor-Positive Tumors: Development and Evaluation of an Albumin-Binding NODAGA-Folate. Farkas R; Siwowska K; Ametamey SM; Schibli R; van der Meulen NP; Müller C Mol Pharm; 2016 Jun; 13(6):1979-87. PubMed ID: 27145400 [TBL] [Abstract][Full Text] [Related]
40. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer. Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]